Wednesday, 22 September 




 09:00 – 12:00
Working Groups

Working Group 1 - ESPE Bone and Growth Plate Working Group
Working Group 2 - ESPE Disorder of Sex Development Working Group
Working Group 3 - ESPE Obesity Club (EOC)
Working Group 4 - ESPE Paediatric and Adolescent Gynaecology Working Group
Working Group 5 - ESPE Study Group on Turner Syndrome (TS)



 12:00 – 12:45
Lunch Break



 12:45 – 13:00
Opening Ceremony



 13:00 - 14:00
Plenary Session 1 - Autoimmunity and Diabetes
Moderator(s): -

Type 1 diabetes epidemiology and genetics in central Europe
Ondrej Cinek, Prague, Czech Republic

Endocrine autoimmunity: lessons from autoimmune polyendocrine syndrome type I
Olle Kämpe, Uppsala, Sweden



 14:00 – 15:30
Coffee Break, Visit to the Posters and Exhibition



 15:30 - 17:00
Symposium 1 - "Bridging Clinical Care and Basic Research" - Ovarian Development
Moderator(s): -

Session Aim: This symposium is part of a series of symposia "Bridging Clinical Care and Basic Science". The aim of the series is to emphasize the impact of patient observation on the understanding of basic biological mechanisms. Each presentation starts with a seminal case presentation, that has led to such development. This symposium is to discuss the pathways involved in ovarian development through gene defects.

FOXL2 and downstream events in ovarian development
Marc Fellous, Paris, France

WnT4 and R-spondin1 signaling in ovarian development
Anna Biason-Lauber, Zurich, Switzerland

SF-1 (NR5A1) and premature ovarian failure
Ken McElreavey, Paris, France



 15:30 - 17:00
Symposium 2 - Diabetes Immunotherapy
Moderator(s): -

Session Aim: The aim of the symposium is to summarize the natural history of type 1 diabetes in humans, to highlight the potential targets for immune intervention and to present two ongoing approaches in recent onset type 1 diabetes: anti-CD3 and GAD vaccination.

Overview of mechanisms and targets of intervention
Christian Boitard, Paris, France

Immunomodulation with specific antigens: the case for GAD 
Johnny Ludvigsson, Linköping, Sweden 

Non-specific immunotherapy: anti-CD3
Kevan C. Herold, New Haven, CT, United States



 15:30 - 17:00
Symposium 3 - IGFs and the Nervous System
Moderator(s): -

Session Aim: The aim is to offer an overview of the role played by IGFs in the development and function of central nervous system, illustrating the potential clinical (diagnostic & therapeutic) implications.

Brain IGF-1 receptors control mammalian growth and lifespan through a neuroendocrine mechanism
Martin Holzenberger, Paris, France

IGF-I in neuromuscular diseases: therapeutic implications
Antonio Musaró, Rome, Italy



 15:30 - 16:30
Meet the Expert 1:1 - Central Diabetes Insipidus

Mohamad Maghnie, Genova, Italy

This session is interactive and located in a smaller room. Seats are limited and will therefore be allocated on a “first-come-first-served” basis, please be on time.



 15:30 - 16:30
Meet the Expert 2:1 - Long Term Follow-Up of Hashimoto Thyroiditis

Marek Niedziela, Poznan, Poland

This session is interactive and located in a smaller room. Seats are limited and will therefore be allocated on a “first-come-first-served” basis, please be on time.



 15:30 - 16:30
Meet the Expert 3:1 - Precocious Puberty - When to Start and Stop Treatment

Lucia Ghizzoni, Parma, Italy

This session is interactive and located in a smaller room. Seats are limited and will therefore be allocated on a “first-come-first-served” basis, please be on time.



 15:30 - 16:30
Meet the Expert 4:1 - Type 2 Diabetes

Silva Arslanian, Pittsburgh, United States

This session is interactive and located in a smaller room. Seats are limited and will therefore be allocated on a “first-come-first-served” basis, please be on time.



 16:30 – 17:15
Break



 17:15 – 18:45
Satellite Symposium
Ipsen



 17:15 – 18:45
Satellite Symposium
Sandoz



 17:15 – 18:45
Satellite Symposium
Novo Nordisk



 18:45 - 00:00
Welcome Reception